At DIANA Biotechnologies we are aiming to become a global leader in PCR clinical diagnostics (IVDR) and offering cutting-edge PCR products and services. We have integrated in-house production capabilities and technology advancements in key areas, such as:

• Enzyme production and development, including new variants with enhanced properties (e.g. polymerase, Reverse Transcriptase, RNAse Inhibitors, UDG)
• Oligonucleotide production and development, using advanced building-block chemistry and large-scale production capabilities
• PCR technology innovations, such as DBdirect™ for robust direct RT-PCR from clinical samples without nucleic acid extraction

We have patented these innovations and used them for our own IVD diagnostics products. Now we are also launching a range of products for life-science market to support other PCR diagnostic producers and academic labs.

Our state-of-the-art manufacturing facilities and advanced technologies enable us to produce every product with the highest purity, quality, and yield. The team of experts is dedicated to delivering the highest quality products and services to you. At our company, we believe in collaboration and are committed to providing expert analysis and assistance to your needs.